| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56449a26d4db6d1825dd063330ed960c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate |
2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8fc5adc0c90c85369cb3edec1adeb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267fa228c2dab96f608ec4ce7f051550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbcda37a89a7cde92ff47683dd3f31ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48421c43ebb89afd34db028aedbba285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_005990f30a7cd060093e66475f788e93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f09bba156242717eb6c0d27f8a0c7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144398341eb7444f8cb883760cedca69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cec09898e7e0defb157ceab5dbe3d120 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021170028-A1 |
| titleOfInvention |
Oral products with reduced irritation |
| abstract |
The disclosure provides products configured for oral use, the products including one or more agents adapted to or configured to reduce irritation that may be associated with release of a component from the products. Xylitol in particular may be useful as an irritation reducing agent. The disclosure further provides methods of reducing irritation associated with the release of one or more components from an oral composition or product. |
| priorityDate |
2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |